Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
92 hedge funds and large institutions have $134M invested in Calithera Biosciences, Inc in 2019 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 4 closing their positions.
575% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 4
174% more call options, than puts
Call options by funds: $444K | Put options by funds: $162K
125% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 16
30% more funds holding
Funds holding: 71 → 92 (+21)
11% less capital invested
Capital invested by funds: $150M → $134M (-$16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$21.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$9.75M |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$4.79M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$3.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
ALPS Advisors
Denver,
Colorado
|
-$621K |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$608K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$474K |
| 4 |
SIM
Spark Investment Management
New York
|
-$218K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$149K |
CALA Hedge Fund Activity: Q2 2019 in Review
92 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2019, worth a combined $134M — down 11% from $150M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new CALA positions and 4 closed out — a net gain of 23 holders — while 36 added to existing stakes and 16 trimmed.
The largest buyer was BVF Inc, adding an estimated $21.2M. The largest seller was ALPS Advisors, exiting entirely with an estimated $621K sold.
- 92 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2019, up from 71 in Q1 2019.
- Funds reported $134M of Calithera Biosciences, Inc stock for Q2 2019, down 11% quarter-over-quarter.
- 27 funds opened new Calithera Biosciences, Inc positions in Q2 2019 and 4 closed out, a net change of +23 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2019 was BVF Inc, an estimated $21.2M added.
- The largest Calithera Biosciences, Inc seller in Q2 2019 was ALPS Advisors, an estimated $621K sold.
Based on aggregated 13F filings for Q2 2019.